4/A//SEC Filing
MCBRINN SYLVIA 4/A
Accession 0001209191-22-038182
CIK 0001826892other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 7:56 PM ET
Size
6.0 KB
Accession
0001209191-22-038182
Insider Transaction Report
Form 4/AAmended
BioAtla, Inc.BCAB
MCBRINN SYLVIA
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-15+18,920→ 18,920 totalExercise: $39.64Exp: 2031-06-15→ Common Stock (18,920 underlying)
Footnotes (2)
- [F1]On June 17, 2021, the reporting person filed a Form 4 in respect of an option covering 24,615 shares. Such option was granted on June 15, 2021 pursuant to the Company's non-employee director compensation policy. The Company subsequently determined that 5,695 of the shares comprising such award were null and void upon grant as a result of the $750,000 annual limit for non-employee director compensation under its 2020 Equity Incentive Plan.
- [F2]1/3 of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, and 1/36th of the total number of shares shall vest monthly thereafter, subject to the reporting person continuing to provide services to the Company through the vesting date.
Documents
Issuer
BioAtla, Inc.
CIK 0001826892
Entity typeother
Related Parties
1- filerCIK 0001284666
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 7:56 PM ET
- Size
- 6.0 KB